Developing treatments for the approximately 7,000 known rare diseases, particularly the subset classified as ultra-rare, presents profound and often insurmountable…
Read More
Fake testimonials, no pharmacy and an FDA warning: how Medvi built a $1.8 billion telehealth company in the gaps between regulators
The recent trajectory of Medvi, a telehealth company projected to achieve a staggering $1.8 billion valuation this year, casts a…
Read More
Protecting Innovation in a Borderless Pharma Economy: The Reality of Globalized Pharma Innovation
Today’s pharmaceutical landscape is characterized by drug development programs that routinely span continents, involving distributed research teams, multinational clinical trial…
Read More
Top pharma companies set sustainability goals, but emissions are still increasing
The global healthcare industry stands as a significant contributor to the planet’s carbon footprint, accounting for an estimated 4.4% of…
Read More
Traumatic brain injury and Alzheimer’s disease, common neuroinflammatory pathologies and therapeutic potential
Traumatic Brain Injury (TBI) stands as a formidable global public health crisis, impacting an estimated 69 million individuals annually across…
Read More
Chinese firms landed 6 of 26 major pharma deals in 16 months, worth $53 billion
Over the past 16 months, Chinese-domiciled biotechnology companies have emerged as significant players in the global pharmaceutical landscape, securing approximately…
Read More
EClinical Solutions Study Models 241% ROI from AI-Powered Clinical Trial Data Platform
A groundbreaking study, commissioned by clinical trial platform company eClinical Solutions and conducted by independent research firm Hobson & Company,…
Read More
Immunai’s Digital ‘Plumbing’ Keeps AstraZeneca Coming Back for Broader, Deeper Collaborations
Immunai, a pioneering startup dedicated to constructing a foundational model of the human immune system, has significantly expanded its strategic…
Read More
A decade in the making: How functional NAMs are redefining cardiac safety assessment
The landscape of drug safety testing is undergoing a profound transformation, marked by the rapid ascent of New Approach Methodologies…
Read More
BioNTech’s Dramatic Pivot: From €19B COVID Vaccine Fortunes to 1,860 Job Cuts and a €16.8B Oncology Bet
The German biotechnology powerhouse BioNTech, once synonymous with its groundbreaking COVID-19 vaccine Comirnaty, is undergoing a profound strategic transformation, shedding…
Read MoreYOU MAY HAVE MISSED
